A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patientsSara Rossi, Giuseppe Campiani, Maria Dichiara et al.|Biomedicine & Pharmacotherapy|2024Cited by 9
p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κBVanessa Tatangelo, Laura Patrussi|Frontiers in Oncology|2022Cited by 7